These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9823021)

  • 1. Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress.
    Iliskovic N; Li T; Khaper N; Palace V; Singal PK
    Mol Cell Biochem; 1998 Nov; 188(1-2):161-6. PubMed ID: 9823021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect.
    Siveski-Iliskovic N; Hill M; Chow DA; Singal PK
    Circulation; 1995 Jan; 91(1):10-5. PubMed ID: 7805190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
    Iliskovic N; Singal PK
    Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc accumulation in adriamycin-induced cardiomyopathy in rats: effects of melatonin, a cardioprotective antioxidant.
    Morishima I; Okumura K; Matsui H; Kaneko S; Numaguchi Y; Kawakami K; Mokuno S; Hayakawa M; Toki Y; Ito T; Hayakawa T
    J Pineal Res; 1999 May; 26(4):204-10. PubMed ID: 10340722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.
    Siveski-Iliskovic N; Kaul N; Singal PK
    Circulation; 1994 Jun; 89(6):2829-35. PubMed ID: 8205698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with probucol prevents adriamycin-induced cardiomyopathy.
    Singal PK; Siveski-Iliskovic N; Hill M; Thomas TP; Li T
    J Mol Cell Cardiol; 1995 Apr; 27(4):1055-63. PubMed ID: 7563102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats.
    Li T; Danelisen I; Belló-Klein A; Singal PK
    Cardiovasc Res; 2000 Jun; 46(3):523-30. PubMed ID: 10912462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy.
    Iliskovic N; Hasinoff BB; Malisza KL; Li T; Danelisen I; Singal PK
    Mol Cell Biochem; 1999 Jun; 196(1-2):43-9. PubMed ID: 10448901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol.
    Li T; Singal PK
    Circulation; 2000 Oct; 102(17):2105-10. PubMed ID: 11044428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol.
    Kumar D; Kirshenbaum LA; Li T; Danelisen I; Singal PK
    Antioxid Redox Signal; 2001 Feb; 3(1):135-45. PubMed ID: 11291592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression.
    Mukherjee S; Banerjee SK; Maulik M; Dinda AK; Talwar KK; Maulik SK
    BMC Pharmacol; 2003 Dec; 3():16. PubMed ID: 14687418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine.
    Hong YM; Kim HS; Yoon HR
    Pediatr Res; 2002 Feb; 51(2):249-55. PubMed ID: 11809922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
    Sayed-Ahmed MM; Salman TM; Gaballah HE; Abou El-Naga SA; Nicolai R; Calvani M
    Pharmacol Res; 2001 Jun; 43(6):513-20. PubMed ID: 11419959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against adriamycin-induced cardiomyopathy by carnosine in rats: role of endogenous antioxidants.
    Dursun N; Taşkın E; Oztürk F
    Biol Trace Elem Res; 2011 Oct; 143(1):412-24. PubMed ID: 20941549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pyrrolidine dithiocarbamate on antioxidant enzymes in cardiomyopathy induced by adriamycin in rats.
    Mingyan E; Hongli L; Shufeng L; Bo Y
    Cardiology; 2008; 111(2):119-25. PubMed ID: 18376123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities.
    Hou XW; Jiang Y; Wang LF; Xu HY; Lin HM; He XY; He JJ; Zhang S
    Toxicol Lett; 2009 May; 187(1):40-4. PubMed ID: 19429242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats.
    Othman AI; El-Missiry MA; Amer MA; Arafa M
    Life Sci; 2008 Oct; 83(15-16):563-8. PubMed ID: 18793653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy.
    Su YW; Liang C; Jin HF; Tang XY; Han W; Chai LJ; Zhang CY; Geng B; Tang CS; Du JB
    Circ J; 2009 Apr; 73(4):741-9. PubMed ID: 19246810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of Centella asiatica on antioxidant tissue defense system against adriamycin induced cardiomyopathy in rats.
    Gnanapragasam A; Ebenezar KK; Sathish V; Govindaraju P; Devaki T
    Life Sci; 2004 Dec; 76(5):585-97. PubMed ID: 15556170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats.
    Yoon HR; Hong YM; Boriack RL; Bennett MJ
    Pediatr Res; 2003 May; 53(5):788-92. PubMed ID: 12621117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.